Epidemiology of Primary Glomerular Diseases in a French Region. Variations According to Period and Age
Overview
Authors
Affiliations
Between January 1, 1976 and December 31, 1990, histological diagnosis of primary glomerular diseases (PGD) was made in 480 patients born and living at the time of diagnosis in a region of France, comprising 410,664 inhabitants, of whom 390,574 were aged from 10 to 80 years. The prevalence of PGD during a 70 year exposure to risk (10 to 80 years of age) was evaluated to 5.7 in 1000 (7.6 in 1000 males and 3.8 in 1000 females). The most common PGD was IgA nephropathy with a prevalence of 1.9 in 1000 (3.3 in 1000 males, 1 in 1000 females). The annual incidence of the disease was evaluated separately for three consecutive five-year periods: period A (1976-80), period B (1981-85), and period C (1986-90). Within each of these three periods the number of patients with PGD was 179, 170 and 131, respectively, and annual incidence was 9.3, 8.8 and 6.7 in 100,000. The incidence of IgA nephropathy remained the same throughout the three periods: 2.6, 3.1 and 2.5 in 100,000. The incidence of membranoproliferative glomerulonephritis decreased from 1981 onward (0.9, 0.5 and 0.15 in 100,000), while that of membranous nephropathy increased slightly (1.2, 1.6 and 1.7 in 100,000). Acute streptococcal glomerulonephritis virtually disappeared during periods B and C. Lipoid nephrosis was less frequent in period C and idiopathic proliferative glomerulonephritis with crescents slightly increased (0.3, 0.4 and 0.6 in 100,000). There was no significant difference between the three periods regarding the incidence of other PGD.(ABSTRACT TRUNCATED AT 250 WORDS)
Gualtieri R, Verolet C, Mardegan C, Papis S, Loevy N, Asner S Eur J Pediatr. 2024; 183(11):4773-4782.
PMID: 39215861 PMC: 11473506. DOI: 10.1007/s00431-024-05705-1.
Time for a relook? An update on primary membranous nephropathy incidence in a large UK cohort.
Storrar J, McDonnell T, Ragy O, Kanigicherla D, Sinha S Clin Kidney J. 2024; 17(4):sfae066.
PMID: 38577270 PMC: 10993060. DOI: 10.1093/ckj/sfae066.
Ishida M, Matsuzaki K, Suzuki H, Suzuki Y, Kawamura T, Marunaka Y Int J Environ Res Public Health. 2022; 19(18).
PMID: 36141738 PMC: 9517453. DOI: 10.3390/ijerph191811466.
Matsuzaki K, Ohigashi T, Sozu T, Ishida M, Kobayashi D, Suzuki H Healthcare (Basel). 2022; 10(9).
PMID: 36141316 PMC: 9498401. DOI: 10.3390/healthcare10091704.
Plasma Homocysteine as a Potential Marker of Early Renal Function Decline in IgA Nephropathy.
Wang Y, Xia H, Song Z, Zhou X, Zhang H Front Med (Lausanne). 2022; 9:812552.
PMID: 35321472 PMC: 8936167. DOI: 10.3389/fmed.2022.812552.